APA

Akuffo E. L., Davis J. B., Fox S. M., Gloger I. S., Hosford D., Kinsey E. E., Jones N. A., Nock C. M., Roses A. D., Saunders A. M., Skehel J. M., Smith M. A. & Cutler P. (20081202). The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone. : Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Chicago

Akuffo Emma L, Davis John B, Fox Steven M, Gloger Israel S, Hosford David, Kinsey Emma E, Jones Neil A, Nock Christina M, Roses Allen D, Saunders Ann M, Skehel J Mark, Smith Marjorie A and Cutler Paul. 20081202. The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone. : Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Harvard

Akuffo E. L., Davis J. B., Fox S. M., Gloger I. S., Hosford D., Kinsey E. E., Jones N. A., Nock C. M., Roses A. D., Saunders A. M., Skehel J. M., Smith M. A. and Cutler P. (20081202). The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone. : Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

MLA

Akuffo Emma L, Davis John B, Fox Steven M, Gloger Israel S, Hosford David, Kinsey Emma E, Jones Neil A, Nock Christina M, Roses Allen D, Saunders Ann M, Skehel J Mark, Smith Marjorie A and Cutler Paul. The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone. : Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 20081202.